The use of in silico technologies for reducing CYP3A4 induction potential in drug discovery

Harutoshi Kato

Presentation information

Symposium

Symposium18「The frontline of ADME related screening and in silico technology」

Sat. Nov 14, 2015 2:00 PM - 4:30 PM Room B (5ＦＳｍａｌｌＨａｌｌ)

Organizer・Chair:Toshiya Moriwaki(Drug Metabolism & Pharmacokinetics Research Laboratories, Takeda Pharmaceutical Company Limited), Chairs:Yoshimasa Kobayashi(Medical safety Research Laboratories, R&D Division, Daiichi Sankyo Co., Ltd.), Fumiyoshi Yamashita(Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University), Harutoshi Kato(DMPK Research Laboratory, Mitsubishi Tanabe Pharma Corporation)

[SY-18-03] The use of in silico technologies for reducing CYP3A4 induction potential in drug discovery

^○Harutoshi Kato (DMPK Research Laboratory, Mitsubishi Tanabe Pharma Corporation)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.